Search clinical trials for: mycophenolate

Total 873 results

University of Texas Southwestern Medical Center
Aspreva Pharmaceuticals

Completed

Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis

Multiple Sclerosis

United States
Nova Scotia Health Authority

Completed

Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney Transplantation

Acute Rejection of Renal Transplant

Canada
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients

Heart Transplantation

United States, Australia, Argentina, Canada
University of Pittsburgh
Stanley Medical Research Institute

Completed

A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Bristol-Myers Squibb

Completed

Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil

Healthy Participants

United States
University of Pittsburgh

Completed

Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention

Graft Versus Host Disease | Allogeneic Blood and Marrow Transplantation (BMT)

United States
University of Texas Southwestern Medical Center
Roche Pharma AG; Biogen

Completed

Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis

Multiple Sclerosis

United States
Novartis Pharmaceuticals

Completed

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107

Renal Transplant
Mayo Clinic
Roche Pharma AG

Completed

CellCept in p-ANCA Vasculitis

Microscopic Polyangiitis | MPO-ANCA Vasculitis

United States
Novartis

Completed

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302

Renal Transplant
Novartis

Completed

Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant

Prevention of Acute Rejection After Kidney Transplantation
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil 250 mg Capsules Under Fasting Conditions

Healthy

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

New Clinical End-points in Patients With Primary Sjögren's Syndrome (NECESSITY)

Primary Sjögren's Syndrome (pSS)

France
East Carolina University
Novartis Pharmaceuticals

Completed

Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

Transplant; Failure, Kidney

United States
Novartis Pharmaceuticals

Completed

A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)

Renal Transplantation
Guy's and St Thomas' NHS Foundation Trust
Institute of Child Health, University College London, London, UK.

Completed

Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) (MISSILE)

Systemic Lupus Erythematosus | Atherosclerosis

United Kingdom
Novartis

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

De Novo Kidney Transplant Recipients
Novartis

Completed

Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Renal Transplantation
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil Tablets Under Fed Conditions

Healthy

Canada
The University of Hong Kong
Queen Mary Hospital, Hong Kong; United Christian Hospital

Completed

Mycophenolate Mofetil for IgA Nephropathy

IGA Nephropathy

China
Assistance Publique - Hôpitaux de Paris

Completed

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT (ATG-CyGVHD)

Graft vs Host Disease

France
Fondo Nacional de Desarrollo Científico y Tecnológico...

Completed

Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection

Kidney Diseases

Chile
Martin, Paul
National Cancer Institute (NCI)

Terminated

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Cancer

United States, Canada
Novartis Pharmaceuticals

Completed

Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate

Autoimmune Disease

Germany
Novartis

Completed

Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus

Prevention of Acute Rejection After Kidney Transplantation
Novartis

Completed

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

Renal Transplant
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil Tablets Under Fasting Conditions

Healthy

Canada
National Institutes of Health Clinical Center (CC)

Completed

Pharmacokinetics of Mycophenolate Mofetil in Healthy Volunteers

Healthy

United States
University Hospital Muenster
Novartis

Completed

Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome

Primary Sjogren's Syndrome

Germany
Third Affiliated Hospital, Sun Yat-Sen University
Beijing Friendship Hospital; Beijing YouAn Hospital; RenJi Hospital; Huashan Hospital and other collaborators

Recruiting

Long-term Benefit of MPA in Liver Transplantation

Liver Transplant Rejection | Immunosuppressant Adverse Reaction

China
Nanjing University School of Medicine

Completed

Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy

IGA Nephropathy

China
Hoffmann-La Roche
Aspreva Pharmaceuticals

Completed

A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.

Myasthenia Gravis Generalised

France, Ukraine, Germany, United States, Italy, United Kingdom, Former Serbia and Montenegro
Novartis Pharmaceuticals

Completed

Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms

Renal Transplant

Korea, Republic of
University Hospital Schleswig-Holstein

Completed

Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation

Renal Transplantation
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells

Idiopathic Inflammatory Myopathy | Interstitial Lung Disease

China
Klemens Budde
Charite University, Berlin, Germany; Dr. med. univ. L. J. Lehner; ERA-EDTA; DESCARTES... and other collaborators

Not yet recruiting

European Transplant Registry of Senior Renal Transplant Recipients on Advagraf (SENIOR)

Infections | Quality of Life | Death | Cardiovascular Risk Factors | Graft Failure | Bone Disease | Post Transplant Diabetes Mellitus | Acute Rejection of Renal Transplant | HLA Antibody Production | Non-HLA Antibody Production
VA Office of Research and Development

Completed

Atomoxetine in Veterans With Comorbid ADHD/PTSD

Attention Deficit Hyperactivity Disorder | Post Traumatic Stress Disorder

United States
Novartis Pharmaceuticals

Completed

Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)

Kidney Maintenance Transplant
Seoul National University Hospital
Chong Kun Dang Pharmaceutical

Completed

Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome

Nephrotic Syndrome

Korea, Republic of
Novartis

Completed

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

Renal Transplantation
University of Michigan
Hoffmann-La Roche

Completed

Pharmacokinetics of Mmf and Valganciclovir

Kidney Transplant Recipient | Heart Transplant Recipient

United States
Novartis

Completed

Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil

Renal Transplantation
Novartis

Completed

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Renal Transplantation
University Hospital, Tours

Not yet recruiting

Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies (INSTEAD)

Renal Transplant Rejection | Induction Therapy
Novartis Pharmaceuticals

Completed

12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients (ATHENA)

Kidney Transplantation | Renal Transplantation

Germany, France
Zhishui Chen

Not yet recruiting

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Kidney Transplant Rejection
Emory University

Recruiting

Abatacept Conversion in Kidney Transplantation

Renal Transplant Recipient

United States
Novartis

Completed

Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy

Liver Transplantation | Kidney Transplantation

Switzerland
EMD Serono
ZymoGenetics

Terminated

The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis

Lupus Nephritis

United States, Singapore, Malaysia, Taiwan, Czech Republic

3

Subscribe